Abstract
In severe COVID-19 patients the blood level of autoantibodies (IgG) to neurospecific proteins was determined. It defined the marked increase in autoantibodies to peripheral myelin protein, protein lipid protein, S100 protein, type 2 dopamine receptors and dopamine. At the same time, it was designate the relationship between the levels of autoantibodies to the S100 protein and NMDA receptors. High levels of specific IgG to SARS-CoV-2 S-Trimer Protein coincided with high levels of autoantibodies to S100 protein and NMDA receptors.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
